Finance

Lists
VEEV:NYSE
Veeva Systems Inc
298,55 USD
-1,02%
(-3,08) 1D
14-окт., 11:35:06 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for VEEV...
Open
300,14 USD
High
301,50 USD
Low
294,59 USD
Mkt. cap
48,34 млд
Avg. vol.
1,47 млн
Volume
345,08 миң
P/E ratio
48,82
52-wk high
309,32 USD
52-wk low
148,05 USD
EPS
6,11 USD
Beta
0,93
Shares outstanding
161,91 млн
No. of employees
8 миң
Open
300,14 USD
High
301,50 USD
Low
294,59 USD
Mkt. cap
48,34 млд
Avg. vol.
1,47 млн
Volume
345,08 миң
P/E ratio
48,82
52-wk high
309,32 USD
52-wk low
148,05 USD
EPS
6,11 USD
Beta
0,93
Shares outstanding
161,91 млн
No. of employees
8 миң
News stories
From web sources and news partners
Profile
Veeva Systems Inc., headquartered in Pleasanton, California, provides cloud computing software, data, and consulting services for the life sciences industry. Its products are used to track all aspects of drug development and pharmaceutical manufacturing. The company has 1,552 customers including Bayer, Boehringer Ingelheim, Eli Lilly and Company, Gilead Sciences, Merck & Co., Novartis, Alkermes plc, Alnylam Pharmaceuticals, bluebird bio, and Idorsia. Wikipedia
About Veeva Systems Inc
CEOPeter Gassner
Employees7,93 миң
Founded2007
HeadquartersПлезантон, Калифорния, Америка Кошмо Штаттары
SectorHealth care
Websiteveeva.com
Analyst ratings
Based on 24 analysts giving stock ratings to VEEV in the past 3 months
Buy
Buy
17
Hold
6
Sell
1
12-month forecast
Based on 24 Wall Street analysts offering 12 month price targets for VEEV in the last 3 months.
Highest
Current 298,55 USD
340,00 USD (+13,88%)
Average
293,57 USD (-1,67%)
Lowest
180,00 USD (-39,71%)
Analyst
Recommendation
Action
Price target
Projected
Date
Joseph Vruwink
Robert W. Baird
Buy
Maintained
300,00 USD
+0,5%
10/09/2026
Stan Berenshteyn
Wells Fargo
Buy
Maintained
330,00 USD
+10,5%
09/30/2026
Craig Hettenbach
Morgan Stanley
Hold
Reiterated
275,00 USD
-7,9%
09/18/2026
Unknown Analyst
CFRA
Buy
Upgraded
-
-
09/16/2026
Charles Rhyee
TD Cowen
Buy
Reiterated
283,00 USD
-5,2%
09/15/2026
Alexei Gogolev
J.P. Morgan
Buy
Maintained
299,00 USD
+0,2%
09/01/2026
Tyler Radke
Citi
Hold
Maintained
273,00 USD
-8,6%
08/28/2026
Brian Peterson
Raymond James
Buy
Maintained
330,00 USD
+10,5%
08/27/2026
Kenneth Wong
Oppenheimer
Buy
Reiterated
325,00 USD
+8,9%
08/27/2026
Gabriela Borges
Goldman Sachs
Sell
Maintained
180,00 USD
-39,7%
08/26/2026
Kirk Materne
Evercore ISI
Hold
Maintained
250,00 USD
-16,3%
08/27/2026
Rishi Jaluria
RBC Capital
Buy
Maintained
325,00 USD
+8,9%
08/26/2026
Sean Dodge
BMO Capital
Hold
Reiterated
270,00 USD
-9,6%
08/27/2026
David Larsen
BTIG
Buy
Maintained
340,00 USD
+13,9%
08/26/2026
Steven Valiquette
Mizuho Securities
Buy
Maintained
280,00 USD
-6,2%
08/27/2026
Karl Keirstead
UBS
Hold
Reiterated
290,00 USD
-2,9%
08/28/2026
Ryan MacDonald
Needham
Buy
Reiterated
310,00 USD
+3,8%
08/27/2026
David Hynes
Canaccord Genuity
Hold
Maintained
260,00 USD
-12,9%
08/27/2026
Tamjid Chowdhury
Guggenheim
Buy
Maintained
310,00 USD
+3,8%
08/27/2026
David Grossman
Stifel Nicolaus
Buy
Maintained
300,00 USD
+0,5%
08/27/2026
Billy Fitzsimmons
Piper Sandler
Buy
Maintained
320,00 USD
+7,2%
08/27/2026
Dylan Becker
William Blair
Buy
Maintained
-
-
08/27/2026
Jailendra Singh
Truist Financial
Buy
Maintained
-
-
08/26/2026
Saket Kalia
Barclays
Buy
Maintained
315,00 USD
+5,5%
08/27/2026
John Difucci
Guggenheim
Buy
Initiated
232,00 USD
-22,3%
07/22/2026
Unknown Analyst
Guggenheim
Buy
Initiated
232,00 USD
-22,3%
07/22/2026
Martin Yang
Oppenheimer
Buy
Reiterated
225,00 USD
-24,6%
06/04/2026
Hannah Rudoff
Piper Sandler
Buy
Maintained
235,00 USD
-21,3%
06/04/2026
Adam Hotchkiss
Goldman Sachs
Sell
Maintained
165,00 USD
-44,7%
06/04/2026
Unknown Analyst
Stephens
Buy
Maintained
324,00 USD
+8,5%
03/05/2026
Bradley Sills
Bank of America Securities
Hold
Maintained
304,00 USD
+1,8%
03/04/2026
Last report
2026-ж., 26-авг.
Fiscal period
Q2 2027
2,35 USD / 2,22 USD
+5,77%beat
Revenue / Est. (USD)
927,96 млн / 905,26 млн
+2,51%beat
Fiscal Q2 2027 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
2025-ж. окт.
2026-ж. янв.
2026-ж. апр.
2026-ж. июл.
Revenue
811,24 млн
835,95 млн
882,95 млн
927,96 млн
Cost of goods sold
199,46 млн
213,48 млн
220,92 млн
232,01 млн
Cost of revenue
199,46 млн
213,48 млн
220,92 млн
232,01 млн
Research and development expenses
191,88 млн
198,79 млн
208,32 млн
222,92 млн
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
179,04 млн
177,80 млн
180,59 млн
198,02 млн
Operating expense
370,92 млн
376,60 млн
388,91 млн
420,93 млн
Total operating expenses
570,38 млн
590,08 млн
609,84 млн
652,94 млн
Operating income
240,85 млн
245,88 млн
273,11 млн
275,02 млн
Other non operating income
-
934,00 миң
-
-
EBT including unusual items
312,79 млн
317,54 млн
347,53 млн
349,53 млн
EBT excluding unusual items
312,79 млн
315,70 млн
345,74 млн
349,53 млн
Income tax expense
76,58 млн
73,33 млн
86,59 млн
76,10 млн
Effective tax rate
24,48%
23,09%
24,92%
21,77%
Other operating expenses
-
-
-
-
Net income
236,20 млн
244,20 млн
260,94 млн
273,43 млн
Net profit margin
29,12%
29,21%
29,55%
29,47%
Earnings per share
2,04
2,06
2,24
2,35
Interest and investment income
71,93 млн
74,35 млн
70,63 млн
72,51 млн
Interest expense
-
-
-
-
Net interest expenses
71,93 млн
74,35 млн
70,63 млн
72,51 млн
Depreciation and amortization charges
-
-
-
-
EBITDA
250,56 млн
254,19 млн
284,70 млн
285,89 млн
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
Google колдонмолору